Eyegate Pharmaceuticals

$4.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.94%) Today
-$0.09 (-2.09%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EYEG and other stocks, options, and ETFs commission-free!

About EYEG

Eyegate Pharmaceuticals, Inc. Common Stock, also called Eyegate Pharmaceuticals, is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye.

CEO
Franz Obermayr
Employees
14
Headquarters
Waltham, Massachusetts
Founded
1998
Market Cap
30.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
13.34K
High Today
$4.31
Low Today
$4.11
Open Price
$4.27
Volume
12.09K
52 Week High
$8.18
52 Week Low
$3.20

EYEG Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

WIW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure